Akebia Therapeutics, Inc.

Contributing Author

Recent Articles by Akebia Therapeutics, Inc.

Jun-04	Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology AKBA GlobeNewswire
Jun-02	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-28	Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025 AKBA GlobeNewswire
May-27	Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025 AKBA GlobeNewswire
May-13	Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference AKBA GlobeNewswire
May-08	Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights AKBA GlobeNewswire
May-01	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-01	Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire